← All companies

SVRA

Savara Inc.

SVRA Nasdaq Pharmaceutical Preparations EDGAR ↗

$5.08

+0.01 +0.20%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$1.04B

Revenue (TTM) ⓘ

$257K

Net income (TTM) ⓘ

-$139M

EPS (TTM) ⓘ

$-0.58

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$101M

Cash ⓘ

$41.8M

Total assets ⓘ

$192M

Gross margin ⓘ

190.3%

52-week range ⓘ

$3.34 – $7.01

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 11, 2026

8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 8, 2026

10-Q Quarter ended 2026-03-31 May 12, 2026

8-K Entered a material agreement Mar 13, 2026

10-K Fiscal year ended 2025-12-31 Mar 13, 2026

8-K Entered a material agreement; Took on a direct financial obligation Jan 27, 2026

8-K Regulation FD disclosure Jan 9, 2026

10-Q Quarter ended 2025-09-30 Nov 12, 2025

8-K Entered a material agreement; Other events Oct 30, 2025

8-K Entered a material agreement; Regulation FD disclosure; Other events Oct 29, 2025

8-K Regulation FD disclosure Sep 2, 2025

10-Q Quarter ended 2025-06-30 Aug 13, 2025

8-K Shareholder vote results Jun 6, 2025

8-K Other events May 27, 2025

10-Q Quarter ended 2025-03-31 May 13, 2025

10-K/A Fiscal year ended 2024-12-31 Apr 25, 2025

8-K Terminated a material agreement Mar 31, 2025

10-K Fiscal year ended 2024-12-31 Mar 27, 2025

8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Regulation FD disclosure Mar 26, 2025

8-K Director or officer change Jan 23, 2025

8-K Regulation FD disclosure Jan 13, 2025

10-Q Quarter ended 2024-09-30 Nov 12, 2024

10-Q Quarter ended 2024-06-30 Aug 12, 2024

8-K Entered a material agreement; Other events Jun 28, 2024

8-K Regulation FD disclosure; Other events Jun 26, 2024

8-K/A Director or officer change Jun 10, 2024

8-K Amended charter or bylaws; Shareholder vote results Jun 7, 2024

10-Q Quarter ended 2024-03-31 May 9, 2024

8-K Entered a material agreement; Director or officer change; Other events Apr 12, 2024

10-K Fiscal year ended 2023-12-31 Mar 7, 2024

8-K Entered a material agreement Feb 16, 2024

8-K Director or officer change Jan 25, 2024

8-K Regulation FD disclosure Jan 5, 2024

10-Q Quarter ended 2023-09-30 Nov 9, 2023

10-Q Quarter ended 2023-06-30 Aug 10, 2023

8-K Entered a material agreement; Other events Jul 13, 2023

8-K Shareholder vote results Jun 9, 2023

8-K Regulation FD disclosure Jun 8, 2023

10-Q Quarter ended 2023-03-31 May 15, 2023

8-K Amended charter or bylaws Mar 30, 2023